Health authorities have ordered a halt to routine semaglutide continuation after dialysis initiation due to a concerning 45–57% rate of serious adverse events in this patient population. To address these risks, a dedicated clinical trial is set to launch, which will incorporate dose-titration and real-time biometric monitoring aimed at establishing a robust safety profile before any broader application of the drug. This proactive measure reflects ongoing scrutiny over the safety of peptide therapies amidst increasing regulatory challenges.
“ClearLake Labs, an emerging leader and rapidly expanding peptide supplier, today announced the expansion of its premium research peptide access across the United States, Canada, and Costa Rica.”
“At the core of ClearLake Labs operations is a comprehensive quality assurance framework built around a dual-layer verification process.”
“Every product is accompanied by a Certificate of Analysis (COA) confirming identity and purity, ensuring that researchers receive materials that meet stringent verification standards.”
“ClearLake Labs is a research materials provider specializing in high-quality peptides for laboratory use.”
“ClearLake Labs ensures fast and reliable shipping across North America.”
“On September 16, 2025, the FDA issued more than 55 warning letters to online sellers of compounded versions of glucagon-like peptide-1 (GLP-1) medications.”
“On February 9, 2026, Novo Nordisk also escalated its enforcement actions by suing Hims & Hers for infringing US Patent No. 8,129,343.”
“These enforcement escalations follow the launch of TrumpRx on February 5, 2026, advertising access to lower-cost, FDA-approved GLP-1 options directly to patients.”
“If such items are not addressed in a satisfactory or timely manner, the FDA has the authority to engage additional advisory action or, without further warning, initiate product recalls, product seizure, injunctions, and criminal actions, which could include civil monetary penalties.”
“Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knockoff Wegovy and Ozempic.”
“In 2021, Jill Eisenstadt-Chayet had reached a breaking point. 'I was sweating as if I was in a sauna all day long and felt like someone dropped a match down my throat,' she says of her perimenopause symptoms.”
“She began a protocol that included GHK-Cu, CJC-1295, and ipamorelin to promote lean muscle mass, collagen production, and tissue regeneration.”
